REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Laboratorios Pronabell S.A.S. (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Laboratorios Pronabell S.A.S. Profile Updated: December 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Colombian company with more than 35 years of experience, dedicated to research, development and commercialization of phytotherapeutic, nutritional and cosmetic pharmaceutical products based on natural active complexes, developed with the state of the art technology and focused on providing outstanding quality products to improve the standard of living of consumers.

Headquarters
Carrera 12 # 24B-45
Funza; Cundinamarca;

Contact Details: Purchase the Laboratorios Pronabell S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Laboratorios Pronabell S.A.S. report to view the information.
Financial Auditors:
Purchase the Laboratorios Pronabell S.A.S. report to view the information.
Incorporation Date:
April 03, 1985
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Company Performance
Financial values in the chart are available after Laboratorios Pronabell S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-1.38%▼
Total operating revenue
-1.39%▼
Operating Profit/Loss (EBIT)
-77.99%▼
EBITDA
-44.85%▼
Net Profit/Loss for the Period
-68.13%▼
Total Assets
-1.82%▼
Total Equity
0.88%▲
Operating Profit Margin (ROS)
-2.48%▼
Net Profit Margin
-1.45%▼
Return on Equity (ROE)
-1.89%▼
Quick Ratio
-0.09%▼
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo